Definitive Contract 75F40124C00137

Award Date 9/26/24
Potential Completion Date 9/26/25
Potential Value $271K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
8(a) Sole Source
Extent Competed
Not Available for Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Leesburg, VA, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $1,996,992.40 Firm Fixed Price contract awarded by the Food and Drug Administration (FDA) to Vets Synergetic Group LLC, an SBA-certified 8(a) joint venture. The contract provides scientific, technical, and strategic program management support services to the FDA. It is an 8(a) sole-source award with a period of performance through September 25, 2025. Vets Synergetic Group LLC holds two significant federal contract Indefinite Delivery Vehicles (IDVs) - a single-award Indefinite Delivery...
This is a $4,395,253.44 definitive, firm-fixed-price contract awarded by the Food and Drug Administration (FDA) to Vets Synergetic Group LLC, a minority-owned, SBA-certified 8(a) small disadvantaged business joint venture. The contract is for business process integration and solution architecture services, with a performance period from April 29, 2024 to April 29, 2029. Vets Synergetic Group LLC holds two significant federal contract vehicles: a single-award Indefinite Delivery Contract (IDC)...
This is a delivery order awarded to Vets Synergetic Group LLC, an SBA-certified 8(a) joint venture and minority-owned small disadvantaged business, by the Food and Drug Administration (FDA). The contract has a ceiling value of $910,080.00 and a period of performance through February 29, 2028. The contract provides scientific, technical, and information technology support services to the FDA, with a focus on the agency's Center for Drug Evaluation and Research (CDER). The services include...
This federal contract award, valued at $4,026,768.00, was issued by the Food and Drug Administration (FDA) to Vets Synergetic Group LLC, an SBA-certified 8(a) joint venture. The contract is a delivery order under the larger IDIQ contract 75F40124D00020, which provides scientific contract professionals to support the research program of the FDA's Center for Drug Evaluation and Research (CDER), Office of Biotechnology Products. The contract does not have a set-aside designation. Vets Synergetic...
This is a firm fixed-price delivery order awarded by the Food and Drug Administration (FDA) to Vets Synergetic Group LLC, a minority-owned, small disadvantaged business structured as a limited liability company and small business joint venture. The purpose of this $231,264.00 task order is to procure the services of a Research Assistant II. The award is not associated with a set-aside program and has an ultimate completion date of June 28, 2026. Vets Synergetic Group LLC holds a $99,883,020.00...
This is a $223,872.00 firm-fixed-price delivery order contract awarded by the Food and Drug Administration (FDA) to Vets Synergetic Group LLC, a minority-owned, small disadvantaged business structured as a limited liability company and small business joint venture. The contract is for a Project Coordinator V to support the FDA and has a period of performance through January 2026. Vets Synergetic Group LLC holds a single-award Indefinite Delivery Contract (IDC) with the FDA valued at...
This is a delivery order award to Vets Synergetic Group LLC, a certified 8(a) small disadvantaged business joint venture, to provide research scientists supporting new and ongoing laboratory research projects for the Food and Drug Administration (FDA). The $6,203,716.80 contract has a period of performance through September 2027 and was awarded in August 2024. Vets Synergetic Group LLC has an existing single-award Indefinite Delivery Contract (IDC) with the FDA valued at $99,883,020.00 for...
This is a task order award issued under a single-award Indefinite Delivery Contract (IDC) with the Food and Drug Administration (FDA), for the CDER Translational Science Program. The $2,082,859.20 task order was awarded to Vets Synergetic Group LLC, an SBA-certified 8(a) joint venture, on August 30, 2024. The contract has a completion date of September 14, 2027 and is a labor hours contract. Vets Synergetic Group LLC is a minority-owned, small disadvantaged business that provides scientific...
This contract is a new task order awarded to Vets Synergetic Group LLC, an SBA-certified 8(a) joint venture, under the FDA-Wide Scientific Support Indefinite Delivery Contract (IDC) 75F40124D00020. The task order is for one (1) pharmaceutical scientist to conduct product quality research for the Food and Drug Administration (FDA). The contract has a ceiling value of $197,644.80 and a period of performance through December 15, 2025. This task order is not set aside and is being awarded under...
This is a task order awarded to Vets Synergetic Group LLC, an SBA-certified 8(a) joint venture, by the Food and Drug Administration (FDA). The task order, valued at $438,282.40, is for IT and research support services to the FDA's Office of Pharmaceutical Quality (OPQ) Laboratories. Vets Synergetic Group LLC is a minority-owned, self-certified small disadvantaged business that provides scientific and information technology services to federal agencies, with a particular focus on supporting the...

This is a $270,974.27 Firm Fixed Price definitive contract awarded by the Food and Drug Administration (FDA) to Vets Synergetic Group LLC, an 8(a) certified small business joint venture. The contract is for the Center for Drug Evaluation and Research (CDER) Bioresearch Monitoring (BIMO) Program Support, with a period of performance through September 26, 2025. Vets Synergetic Group LLC is a minority-owned, disadvantaged small business that provides scientific and information technology services to federal agencies, including prior contracts with the FDA. This award is a sole-source 8(a) set-aside, leveraging Vets Synergetic Group's specialized expertise to support the FDA's BIMO program, which oversees the conduct of clinical trials for new drugs and biologics.

Generated 9/27/24, 9:20 AM